EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Preformulated, Shelf-Stable, Dendritic Cell-Targeting Nanogel mRNA Vaccine Delivery Platform

Amy E Laturski, Verónica Durán, Bruce T Schaar, Maria T Dulay iD, Shirit Einav iD, Joseph M DeSimone iD

Bioconjugate Chemistry · 17.06.2026 · 37 (6) · 1172-1184

DOI: 10.1021/acs.bioconjchem.6c00069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 01.06.2026. Verfasst von Amy E Laturski und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Stanford University, Stanford, California 94305, United States. Hauptthemen laut MEDLINE: Dendritic Cells, RNA, Messenger, Nanogels, Drug Delivery Systems. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bill and Melinda Gates Foundation, Biohub, Biohub Collaborative Postdoctoral Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current mRNA-based vaccine platforms are limited by complex fabrication, stringent cold-chain dependence, and off-target in vivo delivery, restricting their global accessibility and targeting precision. Here we show a modular mRNA delivery platform; our approach integrates inverse microemulsion-derived polymeric nanogels with adsorption-based mRNA loading and the capability for ligand-directed targeting to develop targeted reductively cleavable acrylate-based inverse microemulsion nanogels (TRAINs). By decoupling nanoparticle fabrication from mRNA loading, preformed TRAINs can be stockpiled and later combined with newly designed mRNA, enabling a plug-and-play strategy for rapid adaptation to emerging pathogens, which is particularly advantageous for pandemic preparedness. This architecture supports efficient mRNA association and robust cellular uptake and translation in HEK293T cells. TRAIN also enables postsynthetic surface functionalization; as a proof of concept, CD206-targeted TRAINs promoted selective delivery to antigen-presenting cells (APCs), producing sustained and localized protein expression in BALB/c mice and preferential mRNA delivery to myeloid APCs in heterogeneous human peripheral blood mononuclear cells. Together, these results demonstrate TRAINs as a surface-customizable, adsorption-based mRNA delivery platform with potential for APC-targeted vaccination and rapid, adaptable vaccine deployment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsRNA, MessengerNanogelsDrug Delivery SystemsHumansAnimalsMice, Inbred BALB CHEK293 CellsMicePolyethyleneimine

Substanzen

RNA, MessengerNanogelsPolyethyleneimine

Autor:innen und Institutionen

  • Department of Chemistry, Stanford University, Stanford, California 94305, United States.
  • Department of Medicine and Department of Microbiology and Immunology, Stanford University, Stanford, California 94305, United States.
  • Biohub, San Francisco, California 94158, United States.
  • Canary Center at Stanford for Cancer Early Detection, Department of Radiology, School of Medicine, Stanford University, Stanford, California 94305, United States.
  • Department of Radiology, Stanford University, Stanford, California 94305, United States.
  • Department of Chemical Engineering, Stanford University, Stanford, California 94305, United States.

ORCID-Profile: Maria T Dulay, Shirit Einav, Joseph M DeSimone

Förderung

  • Bill and Melinda Gates Foundation
  • Biohub
  • Biohub Collaborative Postdoctoral Fellowship
  • Katharine McCormick Postdoctoral Fellowship

Zitieren

APA

Laturski, A. E., Durán, V., Schaar, B. T., Dulay, M. T., Einav, S., & DeSimone, J. M. (2026). Preformulated, Shelf-Stable, Dendritic Cell-Targeting Nanogel mRNA Vaccine Delivery Platform. Bioconjugate Chemistry, 37(6), 1172-1184. https://doi.org/10.1021/acs.bioconjchem.6c00069

Vancouver

Laturski AE, Durán V, Schaar BT, Dulay MT, Einav S, DeSimone JM. Preformulated, Shelf-Stable, Dendritic Cell-Targeting Nanogel mRNA Vaccine Delivery Platform. Bioconjugate Chemistry. 2026;37(6):1172-1184. doi:10.1021/acs.bioconjchem.6c00069

BibTeX
@article{Laturski2026,
  author = {Laturski, Amy E and Durán, Verónica and Schaar, Bruce T and Dulay, Maria T and Einav, Shirit and DeSimone, Joseph M},
  title = {Preformulated, Shelf-Stable, Dendritic Cell-Targeting Nanogel mRNA Vaccine Delivery Platform},
  journal = {Bioconjugate Chemistry},
  year = {2026},
  volume = {37},
  number = {6},
  pages = {1172--1184},
  doi = {10.1021/acs.bioconjchem.6c00069}
}
Kostenlos starten →